News

Micardis (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older, at high risk of

Stallergenes has been granted European approval to market Oralair in both adults and children through a Mutual Recognition Procedure. Oralair is an immunotherapy tablet aimed at patients suffering

Hyderabad, India-based Natco Pharma, a generic drug maker, is planing to acquire Teva. The acquisition is said to be in relation to generic Copaxone indicated for multiple sclerosis.

EMEA has validated ChemGenex Pharmaceuticals’ (ChemGenex) Marketing Authorisation Application (MAA) for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib

RTS Life Science (RTS) has upgraded RTS SolidPrep with two new adaptors to support the processing of larger volume, 80ml and 120ml tubes. These larger capacity tubes support

SGS North America (SGS) has received US Patent No 7,596,419 for a Positive Material Identification (PMI) inspection system. The original application was filed on November 18, 2005, and

The FDA has approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B. Agriflu, manufactured by Novartis Vaccines

Ranbaxy Laboratories (Ranbaxy) has obtained FDA approval in the US to market its over-the-counter drug, Acetaminophen tablets. The company said that the tablets will be available in 650mg,

Glycotope has received regulatory approval by Germany and Italian regulatory authorities for a Phase I study of Glycotope’s lead antibody GT-MAB 2.5-GEX for the treatment of various solid